Clinical Trial Update: Potential Impact of Cigarette Smoking on Platelet Reactivity in Patients on Dual Antiplatelet Therapy With P2Y12 Inhibitors [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update examining whether cigarette smoking alters platelet reactivity in patients with coronary artery disease on dual antiplatelet the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• P2Y12 inhibitors

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Coronary Artery Disease | Phase 4 | Status: UNKNOWN